Status:
UNKNOWN
Human Versus Analogue Insulin in Patients After Pancreatectomy.
Lead Sponsor:
Polish Society of Diabetology
Conditions:
Pancreatogenous Diabetes
Eligibility:
All Genders
Up to 90 years
Phase:
PHASE4
Brief Summary
Pancreatectomy is a common treatment modality for both benign and malignant pathologies. One of the most common complications after pancreatectomy is pancreatogenous diabetes mellitus. Yet, insulin re...
Eligibility Criteria
Inclusion
- •Patients with pancreatic tumor confirmed in imaging studies and qualified for surgical treatment
Exclusion
- •Active psychiatric disease not amenable to treatment and hindering cooperation
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04690309
Start Date
July 1 2018
End Date
December 31 2021
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Warsaw Medical University
Warsaw, Poland, 02-091